Cargando…

Effectiveness of image‐guided radiotherapy for locally advanced lung cancer patients treated with definitive concurrent chemoradiotherapy

BACKGROUND: Image‐guided radiotherapy (IGRT) is an advanced radiotherapy technique to improve the precision and accuracy of treatment delivery. A recent randomized controlled trial (RCT) for prostate cancer patients treated with radiotherapy via either IGRT or routine care reported statistically sig...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Ji‐An, Tu, Chih‐Yen, Hsia, Te‐Chun, Fang, Hsin‐Yuan, Li, Chia‐Chin, Chien, Chun‐Ru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471052/
https://www.ncbi.nlm.nih.gov/pubmed/32725779
http://dx.doi.org/10.1111/1759-7714.13596
_version_ 1783578701240205312
author Liang, Ji‐An
Tu, Chih‐Yen
Hsia, Te‐Chun
Fang, Hsin‐Yuan
Li, Chia‐Chin
Chien, Chun‐Ru
author_facet Liang, Ji‐An
Tu, Chih‐Yen
Hsia, Te‐Chun
Fang, Hsin‐Yuan
Li, Chia‐Chin
Chien, Chun‐Ru
author_sort Liang, Ji‐An
collection PubMed
description BACKGROUND: Image‐guided radiotherapy (IGRT) is an advanced radiotherapy technique to improve the precision and accuracy of treatment delivery. A recent randomized controlled trial (RCT) for prostate cancer patients treated with radiotherapy via either IGRT or routine care reported statistically significantly worse overall survival (OS) for those patients treated with IGRT. This raised the concern regarding the effectiveness of IGRT in definitive concurrent chemoradiotherapy (dCCRT) for locally advanced lung cancer (LALC). METHODS: Eligible LALC patients diagnosed between 2011 and 2016 were identified via the Taiwan Cancer Registry. We used propensity score (PS) weighting to balance observable potential confounders between groups. The hazard ratio (HR) of death and other outcomes were compared between IGRT and non‐IGRT. We also evaluated OS in various subgroups. RESULTS: Our primary analysis consisted of 797 patients in whom covariates were well balanced after PS weighing. The HR for death when IGRT was compared with non‐IGRT was 0.96 (95% confidence interval 0.79–1.15, P = 0.65). There were also no significant differences for most of the other outcomes or subgroup analyses. CONCLUSIONS: In this updated nonrandomized study, we found that OS of LALC patients treated with dCCRT was not statistically different between those treated with IGRT versus non‐IGRT. The results should be interpreted with caution given the nonrandomized design. Studies regarding toxicity, local control, or designed as RCT are needed to clarify the role of IGRT. KEY POINTS: SIGNIFICANT FINDINGS OF THE STUDY: The OS of LALC patients treated with dCCRT was not statistically different between those treated with IGRT versus those without IGRT, although the observed HR for death was less than unity (ie, in favor of IGRT). WHAT THIS STUDY ADDS: In this updated nonrandomized study using real world data with additional potential confounders, our study provided a reasonable tentative evidence in the lack of RCT as suggested in the literature.
format Online
Article
Text
id pubmed-7471052
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley & Sons Australia, Ltd
record_format MEDLINE/PubMed
spelling pubmed-74710522020-09-11 Effectiveness of image‐guided radiotherapy for locally advanced lung cancer patients treated with definitive concurrent chemoradiotherapy Liang, Ji‐An Tu, Chih‐Yen Hsia, Te‐Chun Fang, Hsin‐Yuan Li, Chia‐Chin Chien, Chun‐Ru Thorac Cancer Original Articles BACKGROUND: Image‐guided radiotherapy (IGRT) is an advanced radiotherapy technique to improve the precision and accuracy of treatment delivery. A recent randomized controlled trial (RCT) for prostate cancer patients treated with radiotherapy via either IGRT or routine care reported statistically significantly worse overall survival (OS) for those patients treated with IGRT. This raised the concern regarding the effectiveness of IGRT in definitive concurrent chemoradiotherapy (dCCRT) for locally advanced lung cancer (LALC). METHODS: Eligible LALC patients diagnosed between 2011 and 2016 were identified via the Taiwan Cancer Registry. We used propensity score (PS) weighting to balance observable potential confounders between groups. The hazard ratio (HR) of death and other outcomes were compared between IGRT and non‐IGRT. We also evaluated OS in various subgroups. RESULTS: Our primary analysis consisted of 797 patients in whom covariates were well balanced after PS weighing. The HR for death when IGRT was compared with non‐IGRT was 0.96 (95% confidence interval 0.79–1.15, P = 0.65). There were also no significant differences for most of the other outcomes or subgroup analyses. CONCLUSIONS: In this updated nonrandomized study, we found that OS of LALC patients treated with dCCRT was not statistically different between those treated with IGRT versus non‐IGRT. The results should be interpreted with caution given the nonrandomized design. Studies regarding toxicity, local control, or designed as RCT are needed to clarify the role of IGRT. KEY POINTS: SIGNIFICANT FINDINGS OF THE STUDY: The OS of LALC patients treated with dCCRT was not statistically different between those treated with IGRT versus those without IGRT, although the observed HR for death was less than unity (ie, in favor of IGRT). WHAT THIS STUDY ADDS: In this updated nonrandomized study using real world data with additional potential confounders, our study provided a reasonable tentative evidence in the lack of RCT as suggested in the literature. John Wiley & Sons Australia, Ltd 2020-07-29 2020-09 /pmc/articles/PMC7471052/ /pubmed/32725779 http://dx.doi.org/10.1111/1759-7714.13596 Text en © 2020 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Liang, Ji‐An
Tu, Chih‐Yen
Hsia, Te‐Chun
Fang, Hsin‐Yuan
Li, Chia‐Chin
Chien, Chun‐Ru
Effectiveness of image‐guided radiotherapy for locally advanced lung cancer patients treated with definitive concurrent chemoradiotherapy
title Effectiveness of image‐guided radiotherapy for locally advanced lung cancer patients treated with definitive concurrent chemoradiotherapy
title_full Effectiveness of image‐guided radiotherapy for locally advanced lung cancer patients treated with definitive concurrent chemoradiotherapy
title_fullStr Effectiveness of image‐guided radiotherapy for locally advanced lung cancer patients treated with definitive concurrent chemoradiotherapy
title_full_unstemmed Effectiveness of image‐guided radiotherapy for locally advanced lung cancer patients treated with definitive concurrent chemoradiotherapy
title_short Effectiveness of image‐guided radiotherapy for locally advanced lung cancer patients treated with definitive concurrent chemoradiotherapy
title_sort effectiveness of image‐guided radiotherapy for locally advanced lung cancer patients treated with definitive concurrent chemoradiotherapy
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471052/
https://www.ncbi.nlm.nih.gov/pubmed/32725779
http://dx.doi.org/10.1111/1759-7714.13596
work_keys_str_mv AT liangjian effectivenessofimageguidedradiotherapyforlocallyadvancedlungcancerpatientstreatedwithdefinitiveconcurrentchemoradiotherapy
AT tuchihyen effectivenessofimageguidedradiotherapyforlocallyadvancedlungcancerpatientstreatedwithdefinitiveconcurrentchemoradiotherapy
AT hsiatechun effectivenessofimageguidedradiotherapyforlocallyadvancedlungcancerpatientstreatedwithdefinitiveconcurrentchemoradiotherapy
AT fanghsinyuan effectivenessofimageguidedradiotherapyforlocallyadvancedlungcancerpatientstreatedwithdefinitiveconcurrentchemoradiotherapy
AT lichiachin effectivenessofimageguidedradiotherapyforlocallyadvancedlungcancerpatientstreatedwithdefinitiveconcurrentchemoradiotherapy
AT chienchunru effectivenessofimageguidedradiotherapyforlocallyadvancedlungcancerpatientstreatedwithdefinitiveconcurrentchemoradiotherapy